Published in Cancer on September 01, 1978
Lymphomas of true histiocytic origin. Expression of different phenotypes in so-called true histiocytic lymphoma and malignant histiocytosis. Am J Pathol (1991) 0.79
EBM/11 reactivity in malignant histiocytosis. J Clin Pathol (1988) 0.77
Ultrastructural identification of neoplastic histiocytes--monocytes: an application of a newly developed cytochemical technique. Am J Pathol (1982) 0.76
Biopsy findings in malignant histiocytosis presenting as lethal midline granuloma. J Clin Pathol (1982) 0.75
Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood (1997) 4.36
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res (1996) 2.86
Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Cancer Res (1996) 2.35
Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells. Exp Hematol (1993) 2.02
Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. Blood (1998) 1.80
Kinetics of the graft-versus-leukemia response after donor leukocyte infusions for relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation. Blood (1998) 1.59
Monoclonal antibody FMC7 detects a conformational epitope on the CD20 molecule: evidence from phenotyping after rituxan therapy and transfectant cell analyses. Cytometry (2001) 1.52
Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma. Br J Cancer (1999) 1.44
Selective susceptibility of CD34-expressing cells to acquire flow cytometric features of apoptosis/necrosis on exposure to an ammonium chloride-based red blood cell lysing reagent. J Hematother (1998) 1.42
Interference of blood leucocytes in the measurements of immature red cells (reticulocytes) by two different (semi-) automated flow-cytometry technologies. Clin Lab Haematol (1996) 1.42
Refinement of velopharyngoplasty in patients with cleft palate by covering the pharyngeal flap with nasal mucosa from the velum. J Craniomaxillofac Surg (2000) 1.41
Subtypes of T-cell chronic lymphatic leukemia. Cancer (1983) 1.39
Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells. Cell Immunol (1996) 1.38
Paclitaxel as weekly second-line therapy in patients with advanced pancreatic carcinoma. Anticancer Drugs (2000) 1.37
Highly sensitive and specific fluorescence reverse transcription-PCR assay for the pseudogene-free detection of beta-actin transcripts as quantitative reference. Clin Chem (1999) 1.35
Assessment of bone marrow histology in Hodgkin's disease: correlation with clinical factors. Br J Haematol (1982) 1.30
Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group. Ann Oncol (1995) 1.24
Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell. J Clin Oncol (1999) 1.22
Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis. Blood (1994) 1.20
Propagation of large numbers of T cells with natural killer cell markers. Br J Haematol (1994) 1.19
CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma. J Clin Oncol (1998) 1.15
Cytogenic and molecular analysis of an aggressive angiomyxoma. Am J Pathol (1995) 1.15
Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12. Cancer Immunol Immunother (1998) 1.11
Malignant thymoma: current status of classification and multimodality treatment. Ann Hematol (2003) 1.09
Recombinant human erythropoietin in patients with myelodysplastic syndrome and myelofibrosis. Acta Haematol (1993) 1.08
The relevance of alpha-naphthyl acetate esterases to various monocyte functions. Br J Haematol (1985) 1.06
Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet (1989) 1.05
Malignant fibrous histiocytoma: histological patterns and cell types. Pathol Res Pract (1980) 1.04
Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group. Ann Intern Med (1992) 1.02
Metastatic choriocarcinoma transplanted with cadaver kidney: a case report. Cancer (1977) 0.99
Modulation of cell surface markers on NK-like T lymphocytes by using IL-2, IL-7 or IL-12 in vitro stimulation. Cytokine (2000) 0.99
Analysis of the p53 and MDM-2 gene in acute myeloid leukemia. Eur J Haematol (1996) 0.98
Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy. Cancer (1997) 0.98
Repetitive transgenes in C. elegans accumulate heterochromatic marks and are sequestered at the nuclear envelope in a copy-number- and lamin-dependent manner. Cold Spring Harb Symp Quant Biol (2011) 0.97
Quantitative fluorescence flow cytometry: a comparison of the three techniques for direct and indirect immunofluorescence. Cytometry (1998) 0.96
Lymphocyte apoptosis: induction by gene transfer techniques. Gene Ther (1997) 0.96
High-dose chemotherapy in germ cell tumours: a large single centre experience. Eur J Cancer (1998) 0.95
Extracardiac rhabdomyoma: report of different types with light microscopic and ultrastructural studies. Cancer (1982) 0.95
Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen. Br J Haematol (1997) 0.95
Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+ CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 gene. Gene Ther (1998) 0.95
Position specificity of Ki-ras oncogene mutations during the progression of colorectal carcinoma. Oncology (1993) 0.94
[A new type of organelle in peripheral lymphocytes?]. Dtsch Med Wochenschr (1968) 0.93
Quantification of Bcr-Abl transcripts in chronic myelogenous leukemia (CML) using standardized, internally controlled, competitive differential PCR (CD-PCR). Nucleic Acids Res (1996) 0.93
[Giant cell tumor of bone and its problems]. Munch Med Wochenschr (1972) 0.93
Aerosol amphotericin B for prevention of invasive pulmonary aspergillosis. Antimicrob Agents Chemother (1993) 0.93
Adult Wilms' tumor. Report of two cases and review of the literature. Cancer (1995) 0.93
Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison. J Clin Oncol (1995) 0.92
Granulocyte colony-stimulating factor worsens the outcome of experimental Klebsiella pneumoniae pneumonia through direct interaction with the bacteria. Blood (1998) 0.92
Potential of autologous immunologic effector cells for bone marrow purging in patients with chronic myeloid leukemia. Bone Marrow Transplant (1995) 0.92
Monoclonal antibody therapy with CAMPATH-1H in patients with relapsed high- and low-grade non-Hodgkin's lymphomas: a multicenter phase I/II study. Ann Hematol (2001) 0.92
Recent progress on the role of Axl, a receptor tyrosine kinase, in malignant transformation of myeloid leukemias. Leuk Lymphoma (1997) 0.91
The ergastoplasm of lymphocytes in the blood. Ger Med Mon (1968) 0.90
Osteosarcoma: histological evaluation and grading. Arch Orthop Trauma Surg (1979) 0.90
[T-cell-antigen positive, E-rosette negative acute lymphoblastic leukaemia (author's transl)]. Blut (1978) 0.90
The value of immunocytochemical staining of lymph node aspirates in diagnostic cytology. Br J Haematol (1988) 0.89
Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection. Cancer Gene Ther (2000) 0.89
[The fine structure of rat bone marrow in the use of recent aldehyde fixation]. Blut (1966) 0.88
Diagnostic accuracy of CT in circumscript liver disease. AJR Am J Roentgenol (1978) 0.88
[The alveolar soft part sarcoma of the skeletal musculature (author's transl)]. MMW Munch Med Wochenschr (1974) 0.88
[Bilateral intrauterine torsion of the spermatic cord (case report) (author's transl)]. Z Geburtshilfe Perinatol (1977) 0.88
Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial. Hum Gene Ther (2001) 0.88
Malignant histiocytosis. Immunohistochemical characterization on paraffin embedded tissue. Virchows Arch A Pathol Anat Histol (1980) 0.88
Replication of parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral blood. J Virol (1992) 0.88
Complete subtyping of the HLA-A locus by sequence-specific amplification followed by direct sequencing or single-strand conformation polymorphism analysis. Tissue Antigens (1995) 0.87
Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques. Leukemia (1993) 0.87
Epidemiological and clinical aspects of hepatitis G virus infection in blood donors and immunocompromised recipients of HGV-contaminated blood. Vox Sang (1998) 0.87
Classification of leukemic cells with T- and O-ALL-specific antisera. Haematol Blood Transfus (1977) 0.87
Axl, a novel receptor tyrosine kinase isolated from chronic myelogenous leukemia. Semin Hematol (1993) 0.86
Human herpesvirus type 7 in blood donors: detection by the polymerase chain reaction. J Med Virol (1995) 0.86
Circulating CD4+ T lymphocytes with intracellular but no surface CD3 antigen in five of seven patients consecutively diagnosed with angioimmunoblastic T-cell lymphoma. Cytometry (2000) 0.85
Metallosis after osteosynthesis. Pathol Eur (1970) 0.85
Immunohistochemical markers of histiocytic tumors. Hum Pathol (1980) 0.85
Recombinant human interferon-alpha in the treatment of angioimmunoblastic lymphadenopathy: results in 12 patients. Leukemia (1991) 0.84
Wolman's disease: clinical, biochemical and ultrastructural studies in an unusual case without striking adrenal calcification. Eur J Pediatr (1980) 0.84
Incomplete functional differentiation of HL-60 leukemic cells by synthetic lipopeptides. Partial inhibition by pertussis toxin of enhanced superoxide formation. Eur J Biochem (1992) 0.84
Discrimination of HLA-B27 alleles by group-specific amplification followed by solid-phase sequencing. Hum Immunol (1996) 0.84
Multimarker classification of acute lymphoblastic leukemia: evidence for further T subgroups and evaluation of their clinical significance. Blood (1980) 0.84
Presence of human beta- and gamma-herpes virus DNA in Hodgkin's disease. Leuk Res (2000) 0.84
Productive infection of in vitro generated haemopoietic progenitor cells from normal human adult peripheral blood with parvovirus B19: studies by morphology, immunocytochemistry, flow-cytometry and DNA-hybridization. Br J Haematol (1991) 0.84
The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma. Transfusion (1994) 0.83
Analysis of CD34-positive hemopoietic progenitor cells from normal human adult peripheral blood: flow-cytometrical studies and in-vitro colony (CFU-GM, BFU-E) assays. Ann Hematol (1991) 0.83
[Histological grading and typing in osteosarcoma. Comparison with the survival time of 22 patients]. Fortschr Med (1980) 0.83
[Malignant fibrous histiocytoma of the bone (8 years after radiation exposure)]. Arch Orthop Unfallchir (1977) 0.83
Interleukin-7 gene transfer in patients with metastatic colon carcinoma, renal cell carcinoma, melanoma, or with lymphoma. Hum Gene Ther (1994) 0.83
Extraskeletal Ewing's sarcoma. Virchows Arch A Pathol Anat Histol (1978) 0.83
Applicability of an absolute quantitative procedure to monitor intra-individual bcr/abl transcript kinetics in clinical samples from chronic myelogenous leukemia patients. Int J Cancer (2000) 0.83
[Effect of the method on the results of determining T-cell subpopulations]. Dtsch Med Wochenschr (1989) 0.83
Phase I trial of gemcitabine (Gemzar), 24 h infusion 5-fluorouracil and folinic acid in patients with inoperable pancreatic cancer. Anticancer Drugs (1999) 0.83
Elevated reticulocyte count--a clue to the diagnosis of haemolytic-uraemic syndrome (HUS) associated with gemcitabine therapy for metastatic duodenal papillary carcinoma: a case report. Br J Cancer (1999) 0.83
[Value of the "region of interest" technique in the scintigraphic diagnosis of primary bone tumors (author's transl)]. Radiologe (1981) 0.83
[Electron microscopic studies of phagocytosis and effect of pyrogenic stimulating substances in the bone marrow]. Z Zellforsch Mikrosk Anat (1967) 0.83
Expression and mutational analysis of Nm23-H1 in liver metastases of colorectal cancer. Br J Cancer (1994) 0.83
Nodular fasciitis (analysis of 100 cases and review of the literature). Pathol Res Pract (1978) 0.82
Nodular fasciitis and proliferative myositis as variants of one disease entity. Invest Cell Pathol (1980) 0.82